Verastem, Inc. (VSTM)

8.20 +0.22 (+2.76%) USD  |  NASDAQ  |  Sep 04, 16:00
8.10 -0.10 (-1.22%) After-Hours: 20:00
More

Verastem Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Dianthus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade